| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |